Literature DB >> 30965283

Papillary thyroid carcinoma behavior: clues in the tumor microenvironment.

Kensey Bergdorf1, Donna C Ferguson1, Mitra Mehrad1, Kim Ely1, Thomas Stricker1, Vivian L Weiss1.   

Abstract

The prevalence of thyroid carcinoma is increasing and represents the most common endocrine malignancy, with papillary thyroid carcinoma (PTC) being the most frequent subtype. The genetic alterations identified in PTCs fail to distinguish tumors with different clinical behaviors, such as extra-thyroidal extension and lymph node metastasis. We hypothesize that the immune microenvironment may play a critical role in tumor invasion and metastasis. Computational immunogenomic analysis was performed on 568 PTC samples in The Cancer Genome Atlas using CIBERSORT, TIMER and TIDE deconvolution analytic tools for characterizing immune cell composition. Immune cell infiltrates were correlated with histologic type, mutational type, tumor pathologic T stage and lymph node N stage. Dendritic cells (DCs) are highly associated with more locally advanced tumor T stage (T3/T4, odds ratio (OR) = 2.6, CI = 1.4-4.5, P = 5.4 × 10-4). Increased dendritic cells (OR = 3.4, CI = 1.9-6.3, P = 5.5 × 10-5) and neutrophils (OR = 10.5, CI = 2.7-44, P = 8.7 × 10-4) significantly correlate with lymph node metastasis. In addition, dendritic cells positively correlate with tall cell morphology (OR = 4.5, CI = 1.6-13, P = 4.9 × 10-3) and neutrophils negatively correlate with follicular morphology (OR = 1.3 × 10-3, CI = 5.3 × 10-5-0.031, P = 4.1 × 10-5). TIDE analysis indicates an immune-exclusive phenotype that may be mediated by increased galectin-3 found in PTCs. Thus, characterization of the PTC immune microenvironment using three computational platforms shows that specific immune cells correlate with mutational type, histologic type, local tumor extent and lymph node metastasis. Immunologic evaluation of PTCs may provide a better indication of biologic behavior, resulting in the improved diagnosis and treatment of thyroid cancer.

Entities:  

Keywords:  RNA sequencing; immunogenomics; papillary thyroid carcinoma; thyroid cancer; tumor immunology

Mesh:

Substances:

Year:  2019        PMID: 30965283      PMCID: PMC8279427          DOI: 10.1530/ERC-19-0074

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  44 in total

1.  Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data.

Authors:  A R Abbas; D Baldwin; Y Ma; W Ouyang; A Gurney; F Martin; S Fong; M van Lookeren Campagne; P Godowski; P M Williams; A C Chan; H F Clark
Journal:  Genes Immun       Date:  2005-06       Impact factor: 2.676

2.  Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study.

Authors:  Catharina Ihre Lundgren; Per Hall; Paul W Dickman; Jan Zedenius
Journal:  Cancer       Date:  2006-02-01       Impact factor: 6.860

3.  Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States.

Authors:  Lola Rahib; Benjamin D Smith; Rhonda Aizenberg; Allison B Rosenzweig; Julie M Fleshman; Lynn M Matrisian
Journal:  Cancer Res       Date:  2014-06-01       Impact factor: 12.701

Review 4.  Diagnostic utility of galectin-3 in thyroid cancer.

Authors:  Connie G Chiu; Scott S Strugnell; Obi L Griffith; Steven J M Jones; Allen M Gown; Blair Walker; Ivan R Nabi; Sam M Wiseman
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.

Authors:  Weiyuan Fang; Lei Ye; Liyun Shen; Jie Cai; Fengjiao Huang; Qing Wei; Xiaochun Fei; Xi Chen; Haixia Guan; Weiqing Wang; Xiaoying Li; Guang Ning
Journal:  Carcinogenesis       Date:  2014-03-06       Impact factor: 4.944

6.  The expression of tumor-associated macrophages in papillary thyroid carcinoma.

Authors:  Bo Hyun Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2013-09

7.  TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.

Authors:  Taiwen Li; Jingyu Fan; Binbin Wang; Nicole Traugh; Qianming Chen; Jun S Liu; Bo Li; X Shirley Liu
Journal:  Cancer Res       Date:  2017-11-01       Impact factor: 12.701

Review 8.  The Role of Chemokines in Thyroid Carcinoma.

Authors:  Sharinie Yapa; Omar Mulla; Victoria Green; James England; John Greenman
Journal:  Thyroid       Date:  2017-10-16       Impact factor: 6.568

9.  Neutrophils support lung colonization of metastasis-initiating breast cancer cells.

Authors:  Stefanie K Wculek; Ilaria Malanchi
Journal:  Nature       Date:  2015-12-09       Impact factor: 49.962

10.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.

Authors:  Bo Li; Eric Severson; Jean-Christophe Pignon; Haoquan Zhao; Taiwen Li; Jesse Novak; Peng Jiang; Hui Shen; Jon C Aster; Scott Rodig; Sabina Signoretti; Jun S Liu; X Shirley Liu
Journal:  Genome Biol       Date:  2016-08-22       Impact factor: 13.583

View more
  18 in total

1.  Diagnostic Value of Serum lncRNA HOTAIR Combined with Galectin-3 in Benign and Papillary Thyroid Carcinoma.

Authors:  Li Li; Jianjun Wang; Zhongquan Li; Shuang Qiu; Junyu Cao; Yuan Zhao; Zhenfan Huang; Jie He; Feipeng Luo; Kunxian Yang
Journal:  Cancer Manag Res       Date:  2021-08-19       Impact factor: 3.989

2.  GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma.

Authors:  Mengyuan Li; Hongwei Jiang; Shengjiang Chen; Yujin Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  Identifying the Transcriptional Regulatory Network Associated With Extrathyroidal Extension in Papillary Thyroid Carcinoma by Comprehensive Bioinformatics Analysis.

Authors:  Yong Chen; Bo Jiang; Wenlong Wang; Duntao Su; Fada Xia; Xinying Li
Journal:  Front Genet       Date:  2020-05-11       Impact factor: 4.599

Review 4.  The multifaceted anti-cancer effects of BRAF-inhibitors.

Authors:  Laura Croce; Francesca Coperchini; Flavia Magri; Luca Chiovato; Mario Rotondi
Journal:  Oncotarget       Date:  2019-11-12

5.  Immune-related key gene CLDN10 correlates with lymph node metastasis but predicts favorable prognosis in papillary thyroid carcinoma.

Authors:  Zhaolan Xiang; Cheng Zhong; Aoshuang Chang; Junjun Ling; Houyu Zhao; Wei Zhou; Xianlu Zhuo
Journal:  Aging (Albany NY)       Date:  2020-02-11       Impact factor: 5.682

Review 6.  Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome.

Authors:  Myriem Boufraqech; Naris Nilubol
Journal:  Cancers (Basel)       Date:  2019-12-10       Impact factor: 6.639

7.  TRIM30 modulates Interleukin-22-regulated papillary thyroid Cancer cell migration and invasion by targeting Sox17 for K48-linked Polyubiquitination.

Authors:  Wei Li; Fen Li; Weiwei Lei; Zezhang Tao
Journal:  Cell Commun Signal       Date:  2019-12-10       Impact factor: 5.712

8.  Identification of Key Genes in Thyroid Cancer Microenvironment.

Authors:  Kankan Zhao; Hao Yang; Houlong Kang; Aiguo Wu
Journal:  Med Sci Monit       Date:  2019-12-16

9.  Effects of Anti-Cancer Drug Sensitivity-Related Genetic Differences on Therapeutic Approaches in Refractory Papillary Thyroid Cancer.

Authors:  Hyeok Jun Yun; Minki Kim; Sang Yong Kim; Sungsoon Fang; Yonjung Kim; Hang-Seok Chang; Ho-Jin Chang; Ki Cheong Park
Journal:  Int J Mol Sci       Date:  2022-01-09       Impact factor: 5.923

10.  Development and validation of a nomogram based on stromal score to predict progression-free survival of patients with papillary thyroid carcinoma.

Authors:  Jiajia Tang; Shitao Jiang; Qiong Gao; Xuehua Xi; Luying Gao; Ruina Zhao; Xingjian Lai; Bo Zhang; Yuxin Jiang
Journal:  Cancer Med       Date:  2021-07-09       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.